Skip to main content
OpenTrials
Completed

NCT Number: NCT01215461

Factors Associated With Mortality in Neonates

The purpose of this study is to better understand the factors associated with mortality and identify potentially preventable causes of death in neonates who die after receiving health care. As a result, an improved neonatal mortality classification system may be defined.

Completed

Looking for future studies?

Notify Me

Key information

Age range

22 week–44 week

Sex eligibility

All sexes

Study type

Observational

Primary location

Providence Alaska Medical Center

Anchorage, Alaska, 99508, United States

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Neonates for whom healthcare was provided
  • Born alive
  • Neonate greater than or equal to 22 0/7 weeks estimated gestational age

Exclusion criteria

  • Stillborn
  • Fetal demise
  • Neonates less than or equal to 21 6/7 weeks estimated gestational age

Treatment and study plan

Primary outcomes

  1. To better understand the factors associated with mortality and identify potentially preventable causes of death in neonates who die after receiving health care.

    Time frame: neonatal outcomes

Sponsors and collaborators

Lead sponsor

Pediatrix

Other

Registry information

Official study title

Evaluation of Factors Associated With Mortality in Neonates

Important dates

Study start
2010
Primary completion
2012
Study completion
2012
First posted
Oct 6, 2010
Registry last updated
May 14, 2013

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.